AGTC Announces $1B Collaboration with BiogenJuly 13th, 2015 by gainesvillechamber
Sue Washer, President/CEO of Applied Genetic Technologies Corporation, last week announced a deal with Massachusetts-based Biogen that potentially could result in $ billion to the company. Washer says the deal will allow the company to expand the number of research programs, more rapidly develop other therapies, and speed up and increase hiring plans, among other things. AGTC chose to work with Biogen because of demonstrated success in gene therapy technologies.
“We feel Biogen is an ideal partner because they have demonstrated success in developing innovative therapies to treat very complex diseases across a wide variety of technologies, and recently made a significant commitment to advancing gene therapy,” said Washer. “We are thrilled to be collaborating with them.”
AGTC’s announcement is the latest in a long series of UF technology brought to market, and its first billion-dollar spinoff.
Washer was recognized in January at the Chamber’s Annual Meeting as the 2015 Chamber Innovator of the Year for the company’s transformational research as well as its two public offerings last year, which total about $86 million.
For more information, read the Gainesville Sun article here.